Notably, eight other fluoroquinolones (Levofloxacin, Gatifloxacin, Ofloxacin, Moxifloxacin, Marbofloxacin, Sparfloxacin, Perfloxacin and Norfloxacin), some of which are reported as radioprotectors 90 , were not hits in our drug screen (Supplementary Data 1)
[1] [4] When to seek medical attention: Contact your healthcare provider immediately if you experience: Severe or persistent vomiting, signs of dehydration (dizziness, decreased urination) Severe abdominal pain, especially if radiating to your back (may indicate pancreatitis) Right upper abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Decreased urine output or swelling (potential kidney problems) Neck mass, hoarseness, or difficulty swallowing (thyroid tumor warning signs) Severe allergic reactions including swelling of face/lips/tongue or difficulty breathing Visual changes (especially in patients with diabetic retinopathy) Symptoms of hypoglycemia (if taking insulin or sulfonylureas) Persistent nausea lasting beyond the first month or significantly impacting nutritional intake also warrants clinical evaluation
I dont think there has ever been so much excitement for any class of drug going off patent, Siddharth Mittal, chief executive of Biocon, told NY Times
doi: 10.1371/journal.pone.0181970 117
#2 I've been on it 5.5 weeks (1mg/week, split into two doses for the first 4.5 and upped to 1.4mg/week on Tuesday) and no appreciable impact to HR
CJC-1295 works by binding to specific receptors in the pituitary gland, where it stimulates the release of growth hormone
